Neurofibromatosis Therapeutic Acceleration Program (NTAP)

The goals of the NTAP project is to accelerate the pace of drug discovery in Neurofibromatosis, a genetic pre-cancer syndrome that causes the growth of neurofibromas throughout affected patients.

Neurofibromatosis Therapeutic Acceleration Program (NTAP)

NTAP is working with Sage on numerous fronts to accelerate the pace of drug discovery in Neurofibromatosis, a genetic pre-cancer syndrome that causes the growth of neurofibromas throughout affected patients. Broadly Sage is working create a comprehensive data portal for both meta and raw data across all NTAP-funded projects. NTAP investigators upload their data to this site, and the data is opened initially to a small community of investigators. As the data is made publicly available, raw data can be released for broad scientific use. Sage is also assisting with analysis of cell lines derived from plexiform neurofibromas that can serve as a novel platform for future drug screening.

View Project in Synapse


Other Collaborative Science research studies

Accelerating Medicine Partnership in Alzheimer’s Disease

AMP-AD is a public private partnership designed to use systems biology to identify novel targets for AD treatment.

Learn More

The ICGC-TCGA Whole Genome Pan-Cancer Analysis Working Group

The Pan-Cancer Analysis of Whole Genomes (PCAWG) is an effort to combine all ICGC and TCGA whole genome sequencing data to collaboratively attain an integrated understanding of cancer by deriving insights across tumor types.

Learn More

SYNODOS

Synodos is a first-of-its-kind Neurofibromatosis research collaboration dedicated to defeating the rare genetic disorder neurofibromatosis.

Learn More